1887

Journal of General Virology header logo

Volume 78, Issue 8

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS Free

Abstract

Immunological correlates of AIDS-free survival after human immunodeficiency virus type 1 (HIV-1) infection are largely unknown. Cytotoxic T lymphocyte (CTL) responses are generally believed to be a major component of protective immunity against viral infections. However, the relationship between HIV-1-specific CTL responses and disease progression rate is presently unclear. Here we show in twelve HIV-1-infected individuals that detection of Rev-specific CTL precursors (CTLp) early in the asymptomatic stage, as well as detection of Rev- and Tat-specific CTLp later during follow-up, inversely correlate with rapid disease progression. No such correlation was found for detection of CTLp against Gag, RT or Nef. Further studies are required to determine whether a protective mechanism is indeed the basis of the observed correlation. The data presented are in agreement with the hypothesis that CTL against proteins that are important for early viral transcription and translation are of particular importance in protection from rapid disease progression.

  • Published Online:
© Society for General Microbiology Ltd 1997
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-8-1913
1997-08-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/8/9266987.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-8-1913&mimeType=html&fmt=ahah

References

  1. Bollinger R. C., Egan M. A., Chun T., Mathieson B., Siliciano R. F. 1996; Cellular immune responses to HIV-1 in progressive and nonprogressive infections. AIDS 10:S85–S96
     [Google Scholar]
  2. Boom R., Sol C. J. A., Salimans M. M. M., Jansen C. L., Wertheim-vanDillen P. M. E., Van der Noordaa J. 1991; A rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 28:495–503
     [Google Scholar]
  3. Borrow P., Lewicki H., Hahn B. H., Shaw G. M., Oldstone M. B. 1994; Virus-specific CD8 + cytotoxic T-lymphocyte activity associated with control of viraemia in primary human immunodeficiency virus type 1 infection. Journal of Virology 68: 6103–6110
     [Google Scholar]
  4. Borrow P., Lewicki H., Wei X., Horwitz M. S., Peffer N., Meyers H., Nelson J. A., Gairin J. E., Hahn B. H., Oldstone M. B. A., Shaw G. M. 1997; Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Medicine 3:205–211
     [Google Scholar]
  5. Carmichael A., Jin X., Sissons P., Borysiewicz L. 1993; Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. Journal of Experimental Medicine 177:249–256
     [Google Scholar]
  6. Connor R. I., Ho D. D. 1994; Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. Journal of Virology 68:4400–4408
     [Google Scholar]
  7. Couillin I., Culmann-Penciolelli B., Gomard E., Choppin J., Levy J. P., Saragosti S. 1994; Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. Journal of Experimental Medicine 180:1129–1134
     [Google Scholar]
  8. Embretson J., Zupanic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. 1993; Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359–362
     [Google Scholar]
  9. Geretti A. M., Dings M. E. M., Van Els C. A. C. M., Van Baalen C. A., Wijnholds F. J., Borleffs J. C. C., Osterhaus A. D. M. E. 1996; Human immunodeficiency virus type 1 (HIV-1)- and Epstein-Barr virus- specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1-infected persons. Journal of Infectious Diseases 174:34–45
     [Google Scholar]
  10. Goulder P. J. R., Phillips R. E., Colbert R. A., McAdam S., Ogg G., Nowak M., Giangrande P., Luzzi G., Morgan B., Edwards A., McMichael A. J., Rowland-Jones S. 1997; Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Medicine 3:212–217
     [Google Scholar]
  11. Harrer T., Harrer E., Kalams S. A., Barbosa P., Trocha A., Johnson R. P., Elbeik T., Feinberg M. B., Buchbinder S. P., Walker B. D. 1996; Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. Journal of Immunology 156:2616–2623
     [Google Scholar]
  12. Haynes B. F., Pantaleo G., Fauci A. S. 1996; Towards an understanding of the correlates of protective immunity to HIV infection. Science 271:324–328
     [Google Scholar]
  13. Hulskotte E. G., Geretti A. M., Siebelink K. H., Van Amerongen G., Cranage M. P., Rud E. W., Norley S. G., De Vries P., Osterhaus A. D. 1995; Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5). Journal of Virology 69:6289–6296
     [Google Scholar]
  14. Johnson R. P., Walker B. D. 1994; Cytotoxic T lymphocytes in human immunodeficiency virus infection: responses to structural proteins. Current Topics in Microbiology and Immunology 189:35–63
     [Google Scholar]
  15. Jurriaans S., Van Gemen B., Weverling G. J., Van Strijp D., Nara P., Coutinho R., Koot M., Schuitemaker H., Goudsmit J. 1994; The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?. Virology 204:223–233
     [Google Scholar]
  16. Kalams S. A., Johnson R. P., Dynan M. J., Hartman K. E., Harrer T., Harrer E., Trocha A., Blattner W. A., Buchbinder S. P., Walker B. D. 1996; T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones : analysis of quasispecies recognition reveals a dominant response directed at a minor in vivo variant. Journal of Experimental Medicine 183:1669–1679
     [Google Scholar]
  17. Kaslow R. A., Carrington M., Apple R., Park L., Munoz A., Saah A. J., Goedert J. J., Winkler C., O’Brien S. J., Rinaldo C., Detels R., Blattner W., Phair J., Erlich H., Mann D. L. 1996; Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Medicine 2:405–411
     [Google Scholar]
  18. Klein M. R., Miedema F. 1995; Long-term survivors of HIV-1 infection. Trends in Microbiology 3:386–391
     [Google Scholar]
  19. Klein M. R., Keet I. P. M., D’Amaro J., Bende R. J., Hekman A., Mesman B., Koot M., De Waal L. P., Coutinho R. A., Miedema F. 1994; Associations between HLA frequencies and pathogenic features ofhuman immunodeficiency virus type 1 infection in seroconverters from the Amsterdam Cohort of homosexual men. Journal of Infectious Diseases 169:1244–1249
     [Google Scholar]
  20. Klein M. R., Van Baalen C. A., Holwerda A. M., Kerkhof Garde S. R., Bende R. J., Keet I. P. M., Eeftinck-Schattenkerk J. M., Osterhaus A. D. M. E., Schuitemaker H., Miedema F. 1995; Kinetics of Gag- specific CTL responses during the clinical course of HIV-1 infection: different for rapid progressors and long-term asymptomatics. Journal of Experimental Medicine 181:1365–1372
     [Google Scholar]
  21. Koenig S., Conley A. J., Brewah Y. A., Jones G. M., Leath S., Boots L. J., Davey V., Pantaleo G., Demarest J. F., Carter C., Wannebo C., Yannelli J. R., Rosenberg S. A., Lane H. C. 1995; Transfer ofHIV- 1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Medicine 1:330–336
     [Google Scholar]
  22. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D. 1994; Temporal association of cellular immune responses with the initial control of viraemia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68:4650–4655
     [Google Scholar]
  23. Lamhamedi-Cherradi S., Culmann-Penciolelli B., Guy B., Ly T. D., Goujard C., Guillet J. G., Gomard E. 1995; Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS 9: 421–426
     [Google Scholar]
  24. Mellors J. W., Rinaldo C. R.Jr Gupta P., White R. M., Todd J. A., Kingsley L. A. 1996; Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167–1170
     [Google Scholar]
  25. Pantaleo G., Demarest J. F., Soudeyns H., Graziosi C., Denis F., Adelsberger J. W., Borrow P., Saag M. S., Shaw G. M., Sekaly R. P. others 1994; Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463–467
     [Google Scholar]
  26. Phillips R. E., Rowland-Jones S., Nixon D. F., Gotch F. M., Edwards J. P., Ogunlesi A. O., Elvin J. G., Rothbard J. A., Bangham C. R. M., Rizza C. R., McMichael A. J. 1991; Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453–459
     [Google Scholar]
  27. Rammensee H. G., Friede T., Stevanoviic S. 1995; MHC ligands and peptide motifs: first listing. Immunogenetics 41:178–228
     [Google Scholar]
  28. Ranki A., Lagerstedt A., Ovod V., Aavik E., Krohn K. J. 1994; Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Archives of Virology 139:365–378
     [Google Scholar]
  29. Rinaldo C., Huang X. L., Fan Z. F., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M. others 1995; High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term non- progressors. Journal of Virology 69:5838–5842
     [Google Scholar]
  30. Riviere Y., Robertson M. N., Buseyne F. 1994; Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes. Current Topics in Microbiology and Immunology 189:65–74
     [Google Scholar]
  31. Riviere Y., McChesney M. B., Porrot F., Tanneau-Salvadori F., Sansonetti P., Lopez O., Pialoux G., Feuillie V., Mollereau M., Chamaret S. others 1995; Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS- related complex or AIDS. AIDS Research and Human Retroviruses 11:903–907
     [Google Scholar]
  32. Seshamma T., Bagasra O., Trono D., Baltimore D., Pomerantz R. J. 1992; Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences USA: 8910663–10667
     [Google Scholar]
  33. Van Baalen C. A., Klein M. R., Geretti A. M., Keet I. P. M., Miedema F., Van Els C. A. C. M., Osterhaus A. D. M. E. 1993; Selective in vitro expansion of HLA class I-restricted HIV-1 gag specific CD8+ T cells from seropositive individuals : identification of CTL epitopes and precursor frequencies. AIDS 7:781–786
     [Google Scholar]
  34. Van Baalen C. A., Klein M. R., Huisman R. C., Dings M. E. M., Kerkhof Garde S. R., Geretti A. M., Gruters R., Van Els C. A. C. M., Miedema F., Osterhaus A. D. M. E. 1996; Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1. Journal of General Virology 77:1659–1665
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-8-1913
Loading
Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS
J. Gen. Virol. 78, 1913 (1997); https://doi.org/10.1099/0022-1317-78-8-1913
/content/journal/jgv/10.1099/0022-1317-78-8-1913
/content/journal/jgv/10.1099/0022-1317-78-8-1913
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error